MINNETONKA, Minn., Sept. 30 /PRNewswire/ -- American Medical Systems® (AMS) (Nasdaq: AMMD), a leading provider of world-class devices and therapies for male and female pelvic health, today announced the worldwide launch of its revolutionary MoXy Liquid Cooled Fiber for laser treatment of benign prostatic hyperplasia (BPH) or enlarged prostate.
Designed to be used with the recently launched GreenLight XPS (Xcelerated Performance System) 180 Watt laser, the MoXy fiber, with its Active Cooling Cap technology, utilizes 360-degree saline flow to maintain the temperature of the fiber tip for dramatically increased fiber longevity. This combination is 50 percent faster in vaporization speed than the GreenLight HPS® (High Performance System) 120 Watt system, significantly reducing treatment time and operative cost. The new system maintains the same safety profile as the proven GreenLight HPS and PV systems, even with the increase in power.
The MoXy fiber is immediately available in the United States, Europe and Australia. Worldwide commercialization will continue throughout the remainder of 2010.
XPS with the MoXy fiber is the latest in AMS’ world-class portfolio of innovative, technologically advanced solutions to treat a variety of pelvic health conditions. Through its commitment to innovation and continuous improvement, AMS has become the recognized technology leader in men’s and women’s pelvic health markets. For more information about GreenLight XPS and MoXy, visit www.AMSGreenLight.com.
About American Medical Systems:
American Medical Systems, headquartered in Minnetonka, Minnesota, is a diversified supplier of medical devices and procedures to cure incontinence, erectile dysfunction, benign prostatic hyperplasia (BPH), pelvic floor prolapse and other pelvic disorders in men and women. These disorders can significantly diminish one’s quality of life and profoundly affect social relationships. In recent years, the number of people seeking treatment has increased markedly as a result of longer lives, higher quality-of-life expectations and greater awareness of new treatment alternatives. American Medical Systems’ products reduce or eliminate the incapacitating effects of these diseases, often through minimally invasive therapies. The company’s products were used to treat more than 335,000 patients in 2009.
More information about the company and its products can be found at www.AmericanMedicalSystems.com and in the Company’s Annual Report on Form 10-K for 2009 and its other SEC filings.
SOURCE American Medical Systems
